{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:50:04Z","timestamp":1771051804431,"version":"3.50.1"},"reference-count":21,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,19]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>An 80-year-old man with no personal or family history of bleeding, presented to hospital with extensive haematomas and skin bruising after using doxycycline. His basic lab workup was concerning for a coagulopathy with an elevated activated partial thromboplastin time and significant anaemia. Mixing studies and other factor levels were tested that led to the diagnosis of acquired haemophilia A with low factor VIII levels and high factor VIII antibodies. He was started on steroids, but his haemoglobin level continued to drop. Later, during his treatment, he was given multiple therapeutic agents, including cyclophosphamide, rituximab and recombinant factor VII (NovoSeven-R). Gradually factor VIII levels increased and haemoglobin stabilised. The hospital course was complicated by COVID-19 pneumonia leading to acute respiratory distress syndrome; the patient eventually expired due to respiratory failure.<\/jats:p>","DOI":"10.1136\/bcr-2021-244748","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:38:17Z","timestamp":1633084697000},"page":"e244748","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Doxycycline-induced acquired haemophilia A"],"prefix":"10.1136","volume":"14","author":[{"given":"Ejaz","family":"Shah","sequence":"first","affiliation":[{"name":"Internal Medicine, HSHS Saint John's Hospital, Springfield, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin","family":"Abro","sequence":"additional","affiliation":[{"name":"Haematology and Oncology, Southern Illinois University School of Medicine, Springfield, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawwad","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Haematology and Oncology, Southern Illinois University School of Medicine, Springfield, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Haematology and Oncology, Southern Illinois University School of Medicine, Springfield, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"2025082803190482000_14.10.e244748.1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","article-title":"Acquired hemophilia A: a review of recent data and new therapeutic options","volume":"22","author":"Franchini","year":"2017","journal-title":"Hematology"},{"key":"2025082803190482000_14.10.e244748.2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"2025082803190482000_14.10.e244748.3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"2025082803190482000_14.10.e244748.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00289-7"},{"key":"2025082803190482000_14.10.e244748.5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20390"},{"key":"2025082803190482000_14.10.e244748.6","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.5.571"},{"key":"2025082803190482000_14.10.e244748.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl224"},{"key":"2025082803190482000_14.10.e244748.8","unstructured":"Patel RS , Parmar M . Doxycycline Hyclate. StatPearls. Bookshelf ID: NBK555888, 2021."},{"key":"2025082803190482000_14.10.e244748.9","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000440","article-title":"Doxycycline-Induced autoimmune hepatitis","volume":"7","author":"Pan","year":"2020","journal-title":"ACG Case Rep J"},{"key":"2025082803190482000_14.10.e244748.10","first-page":"1","article-title":"Doxycycline-Induced antinuclear antibody and antineutrophil cytoplasmic antibody associated vasculitis: a case report and literature review","volume":"2020","author":"Wriston","year":"2020","journal-title":"Case Rep Rheumatol"},{"key":"2025082803190482000_14.10.e244748.11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ejh.12689","article-title":"Acquired haemophilia: an overview for clinical practice","volume":"95 Suppl 81","author":"Kessler","year":"2015","journal-title":"Eur J Haematol"},{"key":"2025082803190482000_14.10.e244748.12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1055\/s-0037-1616545","article-title":"Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine","volume":"86","author":"Sallah","year":"2001","journal-title":"Thromb Haemost"},{"key":"2025082803190482000_14.10.e244748.13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3171\/jns.1980.53.5.0600","article-title":"Acquired hemophilia, meningioma, and diphenylhydantoin therapy","volume":"53","author":"O'Reilly","year":"1980","journal-title":"J Neurosurg"},{"key":"2025082803190482000_14.10.e244748.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00289-7"},{"key":"2025082803190482000_14.10.e244748.15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.20452\/pamw.142","article-title":"Acquired haemophilia","volume":"117","author":"Buczma","year":"2007","journal-title":"Pol Arch Intern Med"},{"key":"2025082803190482000_14.10.e244748.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01031.x"},{"key":"2025082803190482000_14.10.e244748.17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MBC.0b013e32832fb1b9","article-title":"Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin-induced entities","volume":"20","author":"El-Osta","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025082803190482000_14.10.e244748.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0765"},{"key":"2025082803190482000_14.10.e244748.19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia a","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood"},{"key":"2025082803190482000_14.10.e244748.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587089"},{"key":"2025082803190482000_14.10.e244748.21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jfma.2013.01.006","article-title":"A study of 65 patients with acquired hemophilia A in Taiwan","volume":"114","author":"Huang","year":"2015","journal-title":"J Formos Med Assoc"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-244748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:19:15Z","timestamp":1756376355000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-244748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bcr-2021-244748"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-244748","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}